An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer

被引：0
|
作者：
Xin Zhou
Xiaping Wang
Zebo Huang
Lei Xu
Wei Zhu
Ping Liu
机构：
[1] First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[2] Cancer Center of Nanjing Medical University,Key Laboratory of Human Functional Genomics of Jiangsu Province, Clinical Diabetes Centre of Jiangsu Province
[3] Nanjing Medical University,Department of Thoracic Surgery
[4] The Affiliated Jiangning Hospital of Nanjing Medical University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 33卷
关键词：
Breast cancer; ER status; miRNA signature; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] MICRORNAS AND THEIR POTENTIAL TARGETS ASSOCIATED WITH CHARACTERISTICS OF ER-POSITIVE BREAST CANCER
    Endo, Y.
    Toyama, T.
    Takahashi, S.
    Yoshimoto, N.
    Iwasa, M.
    Asano, T.
    Fujii, Y.
    Yamashita, H.
    BREAST, 2013, 22 : S35 - S35
  • [12] miR-18a activates Wnt pathway in ER-positive breast cancer and is associated with poor prognosis
    Nair, Madhumathy G.
    Prabhu, Jyothi S.
    Korlimarla, Aruna
    Rajarajan, Savitha
    Hari, P. S.
    Kaul, Roma
    Alexander, Annie
    Raghavan, Rohini
    Srinath, B. S.
    Sridhar, T. S.
    CANCER MEDICINE, 2020, 9 (15): : 5587 - 5597
  • [13] A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients
    Jing Li
    Wenbin Jiang
    Qirui Liang
    Guanghao Liu
    Yupeng Dai
    Hailong Zheng
    Jing Yang
    Hao Cai
    Guo Zheng
    BMC Genomics, 21
  • [14] A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients
    Li, Jing
    Jiang, Wenbin
    Liang, Qirui
    Liu, Guanghao
    Dai, Yupeng
    Zheng, Hailong
    Yang, Jing
    Cai, Hao
    Zheng, Guo
    BMC GENOMICS, 2020, 21 (01)
  • [15] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [16] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    Breast Cancer Research, 7
  • [17] Attenuation of ER expression in the ER-positive breast cancer organoids by passages in vitro
    Uematsu, Hiroyuki
    Onuma, Kunishige
    Sugie, Tomoharu
    Inoue, Masahiro
    CANCER SCIENCE, 2023, 114 : 1387 - 1387
  • [18] Predicting late recurrence in ER-positive breast cancer
    Jack Cuzick
    Nature Reviews Clinical Oncology, 2019, 16 : 406 - 408
  • [19] What is the best therapy for ER-positive breast cancer?
    不详
    EJC SUPPLEMENTS, 2004, 2 (09): : 62 - 64
  • [20] Predicting late recurrence in ER-positive breast cancer
    Cuzick, Jack
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) : 406 - 408
12345